It paves way for the launch of Selumetinib 10 mg & 25 mg capsule in India, subject to the receipt of related statutory approvals and licenses
The company does not expect the outcome of this inspection to impact its plans
saRNA is a new platform for the development of medicines and vaccines which uses similar technology to mRNA but with the added ability to self-amplify, thereby expressing proteins for longer, resulting in higher protein levels per dose level
The company is the Clinical Research Organisation of Caplin Point Laboratories
Ampion is directly administered by inhalation and it allows the drug to directly target and attenuate inflammation in the lungs
The bank will provide a complete range of financing options including hospitals, labs, diagnostic centres and equipment manufacturers
It becomes the first ophthalmology biosimilar to gain FDA approval in the United States
The purchaser is a part of the portfolio companies of PE firm True North. The said transaction is not a related party transaction.
The approval will enable the treatment of patients in India living with Essential tremor, tremor-dominant Parkinson's Disease and neuropathic pain
The CASPIAN Phase III trial in extensive-stage small-cell lung cancer is the longest survival follow-up ever reported for immunotherapy treatment in this setting
Subscribe To Our Newsletter & Stay Updated
